Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

Go back to Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
(NASDAQ: VRCA) Delayed: 5.64 +0.01 (0.18%)
Previous Close $5.63    52 Week High
Open $5.63    52 Week Low
Day High $6.19    P/E N/A 
Day Low $5.63    EPS
Volume 105,090